Clinical Trials Directory

Trials / Unknown

UnknownNCT05121532

Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients with Non-segmental Vitiligo before and after phototherapy

Detailed description

This prospective study will include 30 patients with NSV, attending the Outpatient Clinics of Dermatology at Sohag University Hospitals, as well as 30 normal volunteers as control. This study will be submitted for approval by Research and Ethical committees at Sohag Faculty of Medicine. An informed written consent will be obtained from each subject prior to participation in the study after full explanation of the procedure.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTInterleukin-15 and Interleukin-22Serum Interleukin-15 and Interleukin-22 in non segmental vitiligo

Timeline

Start date
2022-01-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2021-11-16
Last updated
2021-11-16

Source: ClinicalTrials.gov record NCT05121532. Inclusion in this directory is not an endorsement.